ditiocarb has been researched along with sb 203580 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chilian, WM; Kolz, C; Potter, B; Reed, R; Rocic, P | 1 |
1 other study(ies) available for ditiocarb and sb 203580
Article | Year |
---|---|
Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.
Topics: Acetophenones; Animals; Blood Flow Velocity; Cells, Cultured; Collateral Circulation; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Ditiocarb; Endothelial Cells; Enzyme Inhibitors; Humans; Imidazoles; Ligation; Male; MAP Kinase Signaling System; Myocardial Reperfusion Injury; NADPH Oxidases; Neovascularization, Physiologic; Onium Compounds; Oxygenases; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2007 |